<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04823273</url>
  </required_header>
  <id_info>
    <org_study_id>19-0918</org_study_id>
    <nct_id>NCT04823273</nct_id>
  </id_info>
  <brief_title>Blood Transfusion Reduction - QI Project</brief_title>
  <official_title>Blood Transfusion Reduction Quality Improvement Project</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Colorado, Denver</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Colorado, Denver</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Blood Banks of large medical centers have large annual budgets, typically millions of&#xD;
      dollars. Blood product wastage results in not only in a loss of the product's cost, but also&#xD;
      of the fees involved in transporting, handling, and administering these products. Optimal&#xD;
      utilization of blood products requires a balance between maximizing patient clinical outcomes&#xD;
      while avoiding unnecessary costs and risks associated with transfusions. This project will&#xD;
      specifically focus on packed red blood cell transfusions (pRBCs). There are clear guidelines&#xD;
      for transfusing pRBCs however these guidelines are not always followed. pRBC transfusions&#xD;
      outside of recommended guidelines is associated with increased risk of harm to patients.&#xD;
&#xD;
      Our aim is to improve adherence to guideline indicated pRBC transfusions for patient in the&#xD;
      UCHealth system thereby decreasing inappropriate (non-guideline indicated) pRBC transfusions.&#xD;
      We will conduct a QI project seeking to improve pRBC transfusion guideline adherence. This&#xD;
      project will involve data review to establish baseline rates, multimodal interventions to&#xD;
      improve adherence to pRBC transfusion guidelines including provider education, modifications&#xD;
      to the electronic ordering interface, and changing blood back policies at participating&#xD;
      institutions.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 5, 2021</start_date>
  <completion_date type="Anticipated">July 2022</completion_date>
  <primary_completion_date type="Anticipated">July 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Blood Transfusions</measure>
    <time_frame>52 weeks</time_frame>
    <description>Number of units transfused and pre-transfusion hemoglobin levels per intervention arm.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Guideline Concordance Measured by Pre-Transfusion Hemoglobin Values Per Transfusion</measure>
    <time_frame>Baseline, 52 weeks</time_frame>
    <description>The American Association of Blood Banks recommends a restrictive threshold of a pre-transfusion hemoglobin level of less than 7.0g/dL for the vast majority of inpatients. This outcome will compare historical data to all three randomized groups.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Guideline Concordance Measured by Number of Units Ordered Per Transfusion</measure>
    <time_frame>Baseline, 52 weeks</time_frame>
    <description>The American Association of Blood Banks recommends a restrictive threshold of a single unit pRBC transfusion for the vast majority of inpatients. This outcome will compare historical data to all three randomized groups.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">1100</enrollment>
  <condition>Blood Transfusion</condition>
  <arm_group>
    <arm_group_label>General improvement</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Using the expertise of the study personnel, electronic-health record system architects working for UCHealth, and incorporating feedback from the users who participated in the user-centered design sessions we made changes to the blood transfusion order-set as well as the &quot;prepare&quot; and &quot;transfuse&quot; orders. The intention of the changes to the interface are to be more intuitive for ordering clinicians.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>In-line help text</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In addition to general improvement changes, subjects exposed to the in-line help text arm receive text detailing evidence-based transfusion recommendations that appear if the most recent hemoglobin level is above 7.0 g/dL. This text appears within the transfusion order but is non-interruptive as it does not require users to acknowledge the text nor does is require any additional keystrokes or clicks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Interruptive alert</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In addition to general improvement changes, subjects exposed to the interruptive alert arm receive text detailing evidence-based transfusion recommendations that appear if the most recent hemoglobin level is above 7.0 g/dL. In contrast to the in-line help text arm, this arm includes an interruptive alert that appears when the user selects the transfusion order. This alert offers users the option to remove the order which results in no-blood product ordered. Alternatively, users may continue to order blood and are asked to select the reason for proceeding with the intended order.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>General improvement</intervention_name>
    <description>Changes to interface to be more intuitive.</description>
    <arm_group_label>General improvement</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>In-line help text</intervention_name>
    <description>General improvement + in-line help text</description>
    <arm_group_label>In-line help text</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Interruptive alert</intervention_name>
    <description>General improvement + interruptive alert</description>
    <arm_group_label>Interruptive alert</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All physicians and nurses with access to order inpatient blood transfusions through a&#xD;
             hospital-based EMR.&#xD;
&#xD;
          -  All physicians and nurses ordering blood for individuals over the age of 18.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  All physicians and nurses ordering blood transfusion ordering blood in the OR&#xD;
&#xD;
          -  Blood ordered through massive transfusion protocol&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Sharon Pincus, MA</last_name>
    <phone>303-949-7116</phone>
    <email>sharon.pincus@cuanschutz.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>UCHealth University of Colorado Hospital</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tyler Anstett, DO</last_name>
      <email>tyler.anstett@cuanschutz.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>March 23, 2021</study_first_submitted>
  <study_first_submitted_qc>March 26, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 30, 2021</study_first_posted>
  <last_update_submitted>June 2, 2021</last_update_submitted>
  <last_update_submitted_qc>June 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>blood transfusion</keyword>
  <keyword>EHR interventions</keyword>
  <keyword>user-centered design</keyword>
  <keyword>high-value care</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

